Open Angle Glaucoma clinical trials
33 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- Travoprost Intraocular Implant + iStent Infinite
- Phase 2/Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
- A Randomized, Double-blind, Parallel-group, Two-arm, Multiple Dose, Multicenter, Bioequivalence Study With Clinical Endpoint in the Treatment of Subjects With Chronic Open-angle Glaucoma or Ocular Hypertension in Both Eyes
- A Trial of Hydrus Microstent Versus Goniotomy
- Direct vs Standard SLT for Glaucoma: A Noninferiority Trial
- Results of Patients With Glaucoma Undergoing Minimally Invasive Glaucoma Surgery in Conjunction With Cataract Surgery
- 24-hour Effect of Rocklatan Compared With Latanoprost in Open Angle Glaucoma and Ocular Hypertension Patients
- Electrical Stimulation for Vision Neuroenhancement in Glaucoma
- Evaluating Injection With the Use of Brimonidine Tartrate Ophthalmic 0.025% on Patients Using Netarsudil 0.02%/Latanoprost 0.005% to Treat Glaucoma
- Safety and Effectiveness of the VisiPlate Aqueous Shunt in Patients With Refractory Open-Angle Glaucoma
- Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
- Evaluating ER-100 for Safety in People With Glaucoma or Non-Arteritic Anterior Ischemic Optic Neuropathy (Optic Nerve Conditions)
- Biomarkers of Ocular Surface Damage in the Setting of Topical Ocular Hypotensive Medication Use
- Single-site Pilot Study Evaluating the Effect of QLS-111 Ophthalmic Solution on Posterior Perfusion and Vessel Dilation
- Safety and Efficacy of iDose® TR With Cataract Surgery vs. Cataract Surgery Alone
- Observational Trial of the Updated Inserter for the Travoprost Intracameral Implant 75mcg
- IOP Reduction in Pigmentary Glaucoma Using DSLT
- Efficacy of Surgical Systems in Combination With Phacoemulsification: a Retrospective Analysis
- Tied Tube Trial in Glaucoma Surgery
- Efficacy of Simbrinza and Rocklatan vs Cosopt and Latanoprost
- Rocklatan vs Latanoprost Post-DSLT
- Standalone iStent Infinite and iDose TR for Management of Moderate to Severe Open Angle Glaucoma
- A Prospective Interventional Cohort Study to Evaluate the Efficacy and Safety of the AquaLumen, a Novel Filtration Procedure for the Treatment of Open Angle Glaucoma
- Topical Insulin for Glaucoma (TING2)
- A Study of Outcomes Following Bio-Reinforced Canaloplasty in Eyes With Open-Angle Glaucoma
- 5-Year Postoperative Outcomes of Patients Who Completed the CREST Study
- Three Year Outcomes of Combined Hydrus Microstent With iTrack Canaloplasty
- Direct vs. Conventional SLT in Open-Angle Glaucoma: A RCT
- External Influences Upon Ocular Homeostasis
- Evaluate Efficacy and Safety of PA5108 Ocular Implants in Primary Open Angle Glaucoma or Ocular Hypertension
- AGN-193408 SR in the Treatment of Open-angle Glaucoma or Ocular Hypertension
- Optic Nerve Head Strain as Biomarker for Glaucoma
- Study of the CycloPen Micro-Interventional System and Long-Term Clinical Outcomes
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Open Angle Glaucoma” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.